<![CDATA[Les publications du Centre Régional de Pharmacovigilance de Champagne Ardenne depuis 2008 :

•   D Bourneau-Martin, C Leclech, A Jamet A, G Drablier, T Trenque, K Juengel, D Heath, L Lagarce, P Lainé-Cessac. Omeprazole-induced drug reaction with eosinophilia and systemic symptoms (DRESS) Eur J Dermatol. 2014
• T Trenque, E Herlem, M Abou Taam, M Dramé. Methylphenidate off-label use and safety
  SpringerPlus Mai 2014
• P de Boissieu, L Kanagaratnam, M Abou Taam, MP Roux, M Dramé, T Trenque.
  Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw underbisphosphonate therapy in the French national pharmacovigilance database.
  Pharmacoepidemiol Drug Saf. 2014 Apr 15. doi: 10.1002/pds.3622. [Epub ahead of print]
• P. de Boissieu, M. Abou Taam, M-P. Roux, L. Kanagaratnam, T. Trenque.
  Bisphosphonate therapy and osteonecrosis of the jaw: a case/non-case study in the French
  national pharmacovigilance database. 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Taipei, 24-27 October 2014.
• B. Demailly, M. Abou Taam, M-L Duchenois, F. Krabansky, M-P. Roux, T. Trenque
  Is there less interaction with atorvastatin and rosuvastatin ? 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Taipei, 24-27 October 2014
• F. Krabansky, M. Abou Taam, B. Demailly, E. Herlem, M-P. Roux, T. Trenque
  Adverse reactions in children: French Data 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Taipei, 24-27 October 2014
• L. Kanagaratnam, M. Abou Taam, M. Heng, P. De Boissieu, M. Roux, T. Trenque
  Effet indésirable médicamenteux grave et leur évitabilité chez les sujets âgés de plus de 65 ans
  Congrès International de Francophone Gérontologie et Gériatrie Liège 2014
  Ger Psychol Neuropsychiatr Vieil, vol. 12, supplément 1, mai 2014 p118
• M. Abou Taam (communication orale). Photosensibility and antipsychotic.
  13th International Society of Pharmacovigilance Annual Meeting. Pise, Italie, 01-04 Octobre 2013.
  Drug Saf. 2013,36,917.T. Trenque, M. Abou Taam, P. de Boissieu, E. Herlem.
• Web traffic: a new tool in Pharmacovigilance. 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Montreal, Canada, 25-28 Août 2013.
  Pharmacoepidemiol Drug Saf. 2013,22,S509.
• M. Abou Taam, T. Trenque. Hallucinations: a case / non case study in the French Pharmacovigilance database. 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Montreal, Canada, 25-28 Août 2013. Pharmacoepidemiol Drug Saf. 2013,22,S315.
• L. Saliba, M. Aboutaam, V. Rousseau, L. Chebane, N. Petitpain, B. Baldin, P. Gillet, JL Montastruc, H.
  Bagheri. TNF Inhibitors Exposure and Cancer? Data of Case/Non Case Study in French PharmacoVigilance Database 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Montreal, Canada, 25-28 Août 2013. Pharmacoepidemiol Drug Saf. 2013.
• A. Breton, M. Abou Taam, M-P. Roux, F. Krabansky, T. Trenque. Differentiation syndrome: an example of underreport. 9ème Congrès de Physiologie de Pharmacologie et de Thérapeutique.
  Poitiers, 22 au 24 Avril 2014. Fundam Clin Pharmacol., 28 (Suppl.1). 30-90 p64
• L. Kanagaratnam, M. Abou Taam, M. Heng, P. de Boissieu, M-P. Roux, T. Trenque. Serious adverse drug effect and preventability in the elderly over 65 years. 9ème Congrès de Physiologie de Pharmacologie et de Thérapeutique. Poitiers, 22 au 24 Avril 2014. Fundam Clin Pharmacol., 28 (Suppl.1). 91-114 p106
• M-P. Roux, M. Abou Taam, E. Herlem, F. Krabansky, T. Trenque. A comparative study in a hospital internal medicine department: spontaneous report versus stimulated report. Fundam Clin Pharmacol., 28 (Suppl.1). 30-90 p51
• L. Saliba, M. Aboutaam, V. Rousseau, L. Chebane, N. Petitpain, B. Baldin, P. Gillet, J.L Montastruc, H.
  Bagheri Etude cas-non cas à partir de 10 ans de notifications dans la Base Nationale de PharmacoVigilance 8ème Congrès de Physiologie de Pharmacologie et de Thérapeutique.
  Angers, 22 au 24 Avril 2013. Fundam Clin Pharmacol. 27 (Suppl.1). 128-140 p35
• L. Saliba, M. Aboutaam, V. Rousseau, L. Chebane, N. Petitpain, B. Baldin, P. Gillet, JL Montastruc,
  H.Bagheri. Cancer in Patients Exposed to anti-TNF: Analysis of the French Spontaneous reporting Database for a Controversial Adverse Drug Reaction 13th International Society of Pharmacovigilance Annual Meeting.Pise, Italie, 01-04 Octobre 2013. Drug Saf. 2013,36,807.
• M Abou Taam, C Rossard, L Cantaloube, N Bouscaren, G Roche, L Pochard, et al.
  Analysis of patients’narratives posted on social media websites on benfluorex’s (Mediator(®) ) withdrawal in France. J Clin Pharm Ther 2014. Feb;39(1):53-5. doi: 10.1111/jcpt.12103. Epub 2013 Oct 21.
• P. de Boissieu, D. Brunel Minette, M. Abou Taam, T. Trenque. BCG osteomyelitis of the lower limb. Thérapie. 2013 Nov 11. http://dx.doi.org/10.2515/therapie/2013055
• T. Trenque, G. Maura, E. Herlem, C. Vallet, E. Solé P. Auriche, M. Dramé. Reports of sexual disorders related to Serotonin Reuptake Inhibitors (SRIs) in the French Pharmacovigilance database: an example of underreporting. Drug Saf. 2013,36,515-519.
•  D. Narbey, D. Jolly, R. Mahmoudi, T. Trenque, F. Blanchard, J-L. Novella, M. Dramé. Relationship between anticholinergic drug use and one-year outcome among elderly people hospitalised in medical warsds via emergency department: the SAFES cohort study. J. Nutr. Health Aging. 2013,17,766-771.
•  M. Dramé, R. Mahmoudi, D. Jolly, A. Rapin, I. Morrone, C. Boyer, P. Nazeyrollas, T. Trenque, Blanchard, J-L. Novella. Social support and six-month outcome among elderly patients hospitalized via emergency department: the SAFES cohort study. Eur. Geriatr. Med. 2013,4,161-166.
•  T. Trenque, E. Herlem, P. Auriche, M. Drame. Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database. Drug Saf.2011,34,1161-1166.
•  L. Javot, S. Tala, J. Scala-Bertola, N. Massy, T. Trenque, B. Baldin, M. Andrejak, P. Gillet, N. Petitpain, le réseau français des Centres Régionaux de Pharmacovigilance. Sarcoïdosis and Anti- TNF: a Paradoxical Class Effect? Analysis of the French Pharmacovigilance System Database and Literature Review. Thérapie. 2011,66,149-154.
• W. Kelly, F. Arellano, J. Barnes, U. Bergman, R. Edwards, A. Fernandez, S. Freedman, D. Goldsmith, K. Huang, J. Jones, R. Mcleay, N. Moore, R. Stather, T. Trenque, W. Troutman, E. Van Puijenbroek, F. Williams, R. Wise. Guidelines for submitting adverse event reports for publication. Thérapie. 2009,64,289-294.
•  A-C. Buire, F. Vitry, G. Hoizey, D. Lamiable, T. Trenque. Overdose of meprobamate: plasma concentration and Glasgow coma scale. Brit J Clin Pharmacol. 2009,68,126-127.
• M. Prudent, M. Drame, D. Jolly, T. Trenque, R. Parjoie, P-O. Lang, D. Somme, I. Lanièce, J-B. Gauvain, J-L. Novella et le Groupe SAFES. Consommation de médicaments potentiellement inappropriés chez les sujets âgés hospitalisés en France. Une analyse transversale d’une cohorte prospective multicentrique (cohorte SAFES). Rev Epidémiol Santé Publique 2009,57,49.
•  S. Mikou, A-C. Buire, T. Trenque. Automédication chez la femme enceinte. Thérapie. 2008,63,415-418.
•  W. Kelly, N. Moore, D-I. Goldsmith, J-K. Jones, T. Trenque, E. Van Puijenbroek. The author’s reply. Drug Saf. 2008,31,356-357.
• M. Prudent, M. Drame, D. Jolly, T. Trenque, R. Parjoie, R. Mahmoudi, P-O. Lang, D. Somme, F.Boyer. Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: Cross-sectional analysis of the prospective, multicentre SAFEs cohort.drugs aging. Drugs Aging. 2008,25,933-946.
• V. Marchaisseau, A. Molia, E. Herlem, M-L. Germain, T. Trenque. Propofol-induced hallucination and dreams. Thérapie. 2008,63,141-144.

]]>